Air Products and Chemicals Inc. (NYSE: APD) has reported earnings for its fourth fiscal quarter (ending September 30) of $3.08 versus $2.57 for the same period a year ago — an increase of 20%. However, […]
For its third fiscal quarter (ending September 30), Zimmer Biomet Holdings Inc (NYSE: ZBH) has reported a -15% decline in E.P.S. from $0.92 a year ago to $0.78 in the current quarter. This performance was […]
Empire Petroleum Corp (NYSEAMERICAN: EP) stock suffered a major decline of -11.0% on 11/7/23. The shares closed at $6.82. The stock has been weak relative to the market over the last nine months and has […]
NETGEAR Inc (NASDAQ: NTGR) has recently experienced meaningful negative changes in fundamentals: significant quarterly sales deceleration occurred, significant quarterly earnings deceleration occurred, and the consensus estimate for December, 2024 decreased significantly. Recent meaningful negative changes […]
ICU Medical Inc (NASDAQ: ICUI) stock suffered a major decline of -17.3% on 11/7/23. The shares closed at $84.34. The stock has declined -14.3% during the last week and has been extremely weak relative to […]
For its third fiscal quarter (ending September 30), Gilead Sciences Inc (NASDAQ: GILD) has reported a 22% increase in E.P.S. from $1.43 a year ago to $1.75 in the current quarter. However, this performance was […]
For its third fiscal quarter (ending September 30), TransAlta Corp (NYSE: TAC) has reported a 513% increase in E.P.S. from $0.23 a year ago to $1.41 in the current quarter. This performance was $1.01 better […]
For its third fiscal quarter (ending September 30), UniQure NV (NASDAQ: QURE) has reported E.P.S. of $-1.88 compared to $-1.02 a year ago. This result fell short of the consensus estimate of $-0.77 by $-1.11. […]
On 11/7/23, ADTRAN Holdings Inc (NASDAQ: ADTN) stock suffered a major decline of -26.5%, closing at $5.39. Relative to the market the stock has been extremely weak over the last nine months and has declined […]
Axsome Therapeutics Inc (NASDAQ: AXSM) has reported a loss for its third fiscal quarter (ending September 30) of $-1.32 versus a loss $-1.07 for the same period a year ago. This performance was $-0.13 short […]
Privacy Statement Terms Of Use ©2024 PriceTarget Research